In recent years, 5Amino1MQ Peptide (abbreviated as 5Amino1MQ), a highly selective smallmolecule peptide inhibitor targeting nicotinamide Nmethyltransferase (NNMT), has exhibited broad application prospects and become a research hotspot in obesity and adipose tissue research due to its unique mechanism, favorable targeting ability, and safety
It plays a huge part in creating and regulating our DNA and red blood cells
Injectable delivery bypasses these variables entirely
[1] This discomfort is usually transient and can be minimized by using proper technique and allowing the solution to come to room temperature before injection
5-Amino-1MQ appears in research contexts involving NNMT pathway research, NAD metabolism models, metabolic signaling studies
or Canada as an ingredient in dietary supplements and neither is approved as a drug, as there is a lack of human clinical research demonstrating their efficacy and safety